Related news for: Dr Andrew Swayne
Mater researchers have shown that new applications of existing drugs has the potential to improve quality of life for people with Myasthenia gravis
New applications of drugs could reduce side effects for Myasthenia gravis patients
Mater's Neurosciences Unit are investigating novel diagnostic markers for autoimmune encephalitis
NMDAR antibody encephalitis and novel diagnostic markers
The Betty McGrath Fellowship enables practising Mater clinicians or other health professionals to increase their research activity by providing salary support to back-fill their positions.
Betty McGrath Fellowship recipient’s announced for 2017